Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pharmaceutical Vaneck ETF (PPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fund basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 265,144,100
  • Shares Outstanding, K 4,738

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.44 +2.17%
on 11/02/17
58.32 -4.63%
on 10/23/17
-2.70 (-4.63%)
since 10/20/17
3-Month
53.83 +3.33%
on 08/21/17
58.65 -5.17%
on 10/04/17
+1.55 (+2.87%)
since 08/18/17
52-Week
50.35 +10.47%
on 12/07/16
60.47 -8.02%
on 06/26/17
+2.83 (+5.36%)
since 11/18/16

Most Recent Stories

More News
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 41.68 (-0.53%)
JNJ : 137.93 (-0.05%)
MRK : 54.10 (-1.99%)
PJP : 61.84 (-0.51%)
IHE : 149.59 (-0.67%)
LLY : 83.18 (+0.35%)
PPH : 55.62 (-0.68%)
PFE : 35.35 (-0.06%)
BMY : 60.80 (-0.85%)
Pharma ETFs Down Post Q3 Earnings

The string of earnings beat failed to boost pharma ETFs as they saw rough trading over the past one month.

XPH : 41.68 (-0.53%)
JNJ : 137.93 (-0.05%)
MRK : 54.10 (-1.99%)
PJP : 61.84 (-0.51%)
IHE : 149.59 (-0.67%)
LLY : 83.18 (+0.35%)
PPH : 55.62 (-0.68%)
PFE : 35.35 (-0.06%)
BMY : 60.80 (-0.85%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 41.68 (-0.53%)
PJP : 61.84 (-0.51%)
IHE : 149.59 (-0.67%)
PPH : 55.62 (-0.68%)
What Lies in Store for Pharma ETFs?

Pharma stocks have done well this year; what lies ahead?

XPH : 41.68 (-0.53%)
PJP : 61.84 (-0.51%)
IHE : 149.59 (-0.67%)
PPH : 55.62 (-0.68%)
CORRECTING and REPLACING Announcing VanEck Vectors Equity ETF's September 2017 Distributions

The Record Date for the release dated September 29, 2017 should read: October 3 (instead of October 4).

PPH : 55.62 (-0.68%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 41.68 (-0.53%)
PJP : 61.84 (-0.51%)
IHE : 149.59 (-0.67%)
PPH : 55.62 (-0.68%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 41.68 (-0.53%)
PJP : 61.84 (-0.51%)
IHE : 149.59 (-0.67%)
PPH : 55.62 (-0.68%)
Trump Wins Healthcare Vote: ETFs to Watch

The bill is expected to cut billions of dollars in health-care spending and result in millions of Americans going without health insurance.

HUM : 233.48 (+0.01%)
XHS : 57.01 (-0.74%)
CNCR : 24.57 (-0.24%)
IHF : 146.70 (-0.07%)
HCA : 74.61 (-0.84%)
PPH : 55.62 (-0.68%)
IHI : 174.56 (+0.13%)
UNH : 210.25 (+0.17%)
THC : 13.17 (-0.53%)
AET : 174.94 (+1.00%)
XPH : 41.68 (-0.53%)
FBT : 121.64 (-0.61%)
FTXH : 19.95 (-0.82%)
Trump Wins Healthcare Vote: ETFs to Watch

The bill is expected to cut billions of dollars in health-care spending and result in millions of Americans going without health insurance.

HUM : 233.48 (+0.01%)
XHS : 57.01 (-0.74%)
CNCR : 24.57 (-0.24%)
IHF : 146.70 (-0.07%)
HCA : 74.61 (-0.84%)
PPH : 55.62 (-0.68%)
IHI : 174.56 (+0.13%)
UNH : 210.25 (+0.17%)
THC : 13.17 (-0.53%)
AET : 174.94 (+1.00%)
XPH : 41.68 (-0.53%)
FBT : 121.64 (-0.61%)
FTXH : 19.95 (-0.82%)
Should You Buy Pharma ETFs Now?

After a challenging 2016, are Pharma ETFs poised to rebound this year?

XPH : 41.68 (-0.53%)
PJP : 61.84 (-0.51%)
IHE : 149.59 (-0.67%)
PPH : 55.62 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More

Fund Summary

The VanEck Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical...

See More

Key Turning Points

2nd Resistance Point 55.97
1st Resistance Point 55.80
Last Price 55.62
1st Support Level 55.45
2nd Support Level 55.27

See More

52-Week High 60.47
Fibonacci 61.8% 56.60
Last Price 55.62
Fibonacci 50% 55.41
Fibonacci 38.2% 54.22
52-Week Low 50.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart